Company ProfilePremium

Leica Biosystems

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Leica Biosystems - Healthcare showcase

Year Founded & Workforce

1989

80,000 Employees

Industry

Healthcare

Services

Breast Biopsy Products
L

Leica Biosystems Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Leica Biosystems Overview

Company Headquarters: Germany

Founded: 1989

Workforce: The company has employed more than 80,000 employees throughout the world.

Company Working: Leica Biosystems is a global leader in developing and manufacturing innovative solutions for cancer diagnosis. Their product portfolio includes a range of instruments, reagents, and consumables used in the preparation and analysis of tissue samples for cancer diagnosis and research. One of the products offered by Leica Biosystems is their breast biopsy product, which includes a range of instruments, reagents, and consumables used for breast biopsy procedures. These products help to ensure accurate and efficient collection of breast tissue samples, which can then be analysed for the presence of cancer.

Strategy

Leica Biosystems' growth strategy includes expanding its product and service offerings, increasing its global presence, leveraging technology to improve its offerings, investing in research and development to create new products and services, and pursuing strategic partnerships and acquisitions to expand its capabilities and reach.

Company Snapshot

80,000

Employees

1989

Founded

Germany

Headquarters

SWOT Analysis

Strengths

  • Strong brand reputation in the field of cancer diagnosis, with a focus on innovative solutions for improving accuracy and efficiency.

Weaknesses

  • High product costs, which may limit adoption in certain markets and by certain customers.

Opportunities

  • Increasing demand for cancer diagnosis and treatment, especially in emerging markets.
  • Expansion into new product lines or partnerships, such as digital pathology and precision medicine.

Threats

  • Intense competition from other companies in the cancer diagnosis and research industry.
  • Regulatory and compliance challenges, as well as changes in reimbursement policies for healthcare services.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Leica Biosystems
    • Breast Biopsy Products

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.